These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 22785526

  • 1. SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma.
    Chang CC, Cho SF, Chen YW, Tu HP, Lin CY, Chang CS.
    Clin Nucl Med; 2012 Aug; 37(8):e189-95. PubMed ID: 22785526
    [Abstract] [Full Text] [Related]

  • 2. Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
    Papajík T, Mysliveček M, Sedová Z, Buriánková E, Procházka V, Koranda P, Raida L, Kubová Z, Palová M, Kučerová L, Flodr P, Jarkovský J, Dušek L, Indrák K.
    Eur J Haematol; 2011 Jan; 86(1):32-7. PubMed ID: 20874822
    [Abstract] [Full Text] [Related]

  • 3. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Acta Radiol; 2015 Oct; 56(10):1230-5. PubMed ID: 25387723
    [Abstract] [Full Text] [Related]

  • 4. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [Abstract] [Full Text] [Related]

  • 5. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
    Chen-Liang TH, Martin-Santos T, Jerez A, Senent L, Orero MT, Remigia MJ, Muiña B, Romera M, Fernandez-Muñoz H, Raya JM, Fernandez-Gonzalez M, Lancharro A, Villegas C, Carlos Herrera J, Frutos L, Luis Navarro J, Uña J, Igua C, Sanchez-Vaño R, Cozar Mdel P, Contreras J, Sanchez-Blanco JJ, Perez-Ceballos E, Ortuño FJ.
    Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
    [Abstract] [Full Text] [Related]

  • 6. Correlations between maximum standardized uptake value measured via 18F-fluorodeoxyglucose positron emission tomography/computed tomography and clinical variables and biochemical indicators in adult lymphoma.
    Li H, Wang X, Zhang L, Yi X, Qiao Y, Jin Q.
    J Cancer Res Ther; 2019 Aug; 15(7):1581-1588. PubMed ID: 31939441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, Dygai-Cochet I, Legouge C, Casasnovas O, Brunotte F.
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [Abstract] [Full Text] [Related]

  • 9. Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma.
    Shinya T, Fujii S, Asakura S, Taniguchi T, Yoshio K, Alafate A, Sato S, Yoshino T, Kanazawa S.
    Ann Nucl Med; 2012 Oct; 26(8):616-21. PubMed ID: 22692457
    [Abstract] [Full Text] [Related]

  • 10. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma.
    Watanabe R, Tomita N, Takeuchi K, Sakata S, Tateishi U, Tanaka M, Fujita H, Inayama Y, Ishigatsubo Y.
    Leuk Lymphoma; 2010 Feb; 51(2):279-83. PubMed ID: 20038236
    [Abstract] [Full Text] [Related]

  • 11. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
    Cho SF, Chang CC, Liu YC, Chang CS, Hsiao HH, Liu TC, Huang CT, Lin SF.
    Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
    [Abstract] [Full Text] [Related]

  • 12. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC.
    Nucl Med Commun; 2016 Jan; 37(1):23-9. PubMed ID: 26440567
    [Abstract] [Full Text] [Related]

  • 13. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
    Mosavi F, Wassberg C, Selling J, Molin D, Ahlström H.
    Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
    [Abstract] [Full Text] [Related]

  • 14. [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
    Buchmann I, Vogg AT, Glatting G, Schultheiss S, Möller P, Leithäuser F, Schulte M, Gfrörer W, Kotzerke J, Reske SN.
    Cancer Biother Radiopharm; 2003 Jun; 18(3):327-37. PubMed ID: 12954120
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
    Zhang Q, Tian T, Wang L, Qiu H, Li D.
    Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
    [Abstract] [Full Text] [Related]

  • 16. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
    Koç M, Kaya GÇ, Demir Y, Sürücü E, Sarioğlu S, Obuz F, Öztop İ, Görken İB, Sökmen S.
    Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176
    [Abstract] [Full Text] [Related]

  • 17. Hybrid FDG-PET/MR compared to FDG-PET/CT in adult lymphoma patients.
    Atkinson W, Catana C, Abramson JS, Arabasz G, McDermott S, Catalano O, Muse V, Blake MA, Barnes J, Shelly M, Hochberg E, Rosen BR, Guimaraes AR.
    Abdom Radiol (NY); 2016 Jul; 41(7):1338-48. PubMed ID: 27315095
    [Abstract] [Full Text] [Related]

  • 18. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
    Akkas BE, Vural GU.
    Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
    [Abstract] [Full Text] [Related]

  • 19. [Positron emission tomography with 18F-FDG compared with proliferative activity of tumor cells in different subtypes of non-Hodgkin lymphoma].
    Tiutin LA, Khodzsibekova MM, Pozharisskiĭ KM, Mukhina MS, Kostenikov NA, Il'in NV.
    Vopr Onkol; 2011 Jan; 57(6):748-52. PubMed ID: 22416392
    [Abstract] [Full Text] [Related]

  • 20. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.
    Muslimani AA, Farag HL, Francis S, Spiro TP, Chaudhry AA, Chan VC, Taylor HC, Daw HA.
    Am J Clin Oncol; 2008 Oct; 31(5):409-12. PubMed ID: 18838874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.